Tirzepatide
(Compounded GLP-1)
$1000 $390-$490/session
- Injection: Tirzepatide/B12
- Prescription requires a BMI of 30+ (27+ in special cases) to qualify for purchase.
- The course of tirpatide is calculated on a monthly basis, and follow-up visits are required every month
Have you been looking for a way to lose weight that is both safe and effective? Tirzepatide is the perfect choice for you! As the latest weight loss miracle drug, tirzepatide combines the dual hormonal functions of GLP-1 and GIP, which not only effectively controls appetite, but also significantly improves blood sugar levels. Tirzepatide has been proven in clinical trials to excel in helping patients lose weight, with an average weight loss of 15-20%. Compared to other weight loss medications, tirzepatide has fewer side effects, is easy to use, and only needs to be injected once a week to enjoy long-lasting weight loss results. Whether you’re looking to get rid of stubborn fat or improve your quality of life with healthy weight loss, Tirzepatide is an option you shouldn’t miss. Consult a doctor today and start your new life of lightness!
At Mojoon, you can conveniently consult a licensed physician online to get personalized prescriptions and prescriptions and medications. You don’t have to endure the pain of dieting and the exhaustion of exercise, you can start your weight loss journey in just one step. Choose tirzepatide and let’s march towards a healthy and beautiful future together!
- Legit prescription
- 100% Privacy
- FDA 503B Pharmacy
- Online consultation, no talking needed
- No 3rd-Party Info sharing
- HIPAA Compliance
What is Compound Tirzepatide?
Tirzepatide offered by Mojoon is formulated and synthesized by FDA 503B qualified compounding pharmacies. Compounding medication is the process of tailoring a drug to the needs of an individual patient. For example, some patients may need medications in liquid form, while FDA-approved drugs come in pill form. In addition, pharmacies can compound FDA-approved drugs that are in short supply.
Compounded drugs are prepared by state-licensed compounding pharmacies that meet FDA and state requirements, including quality standards. When compounding in compliance with federal law, compounded drugs are not subject to FDA approval and do not have to undergo safety, effectiveness, or manufacturing review.
Mojoon has partnered with FDA-cleared 503B compounding pharmacies to offer tirzepatide which contains the same active ingredients as Mounjaro and Zepbound. Only FDA503B compound pharmaceutical companies can prepare prescription drugs that require sterile injections, and no other pharmacy has such qualifications. FDA 503B drug compounds are guaranteed from the source and production level of drugs, so there is no need to worry about purchasing drugs without the assurance of quality and safety.
What's included
The course of tirzepatide is calculated on a monthly basis, with 1 injection per week and 4 injections per week. After completing a course of treatment, you will need to fill out a follow-up questionnaire to get a prescription from your doctor for the next course of treatment. The initial dose of tirzepatide is 2.5 mg and is increased monthly depending on the situation, with a maximum weekly dose of 15 mg.
Side effects
The most common side effects may include:
1. Gastrointestinal problems: Nausea, diarrhea, vomiting, constipation, and abdominal pain are especially common after starting the medication or increasing the dose.
2. Loss of appetite: Many people experience a decrease in hunger, which helps in weight loss.
3. Hypoglycemia: Tirpatide may cause hypoglycemia, especially when used with other hypoglycemic drugs.
4. Injection site reactions: Redness, itching, or swelling may occur at the injection site.
5. Fatigue: Some people may feel unusually tired.
It is important to monitor these side effects and discuss any concerns with a medical provider who can provide guidance on managing these side effects or adjust the treatment plan as needed.
Why Tirzepatide?
Visible weight loss
In a 72-week clinical trial, participants who took tirzepatide and made lifestyle changes lost 15% (5 mg dose) and 19.5% (10 mg dose), respectively. and 20.9% (15 mg dose) of body weight. Participants in the placebo group lost only 3.1% of their body weight.
Improves insulin sensitivity
Five clinical trials have demonstrated the efficacy of tirzepatide in lowering blood sugar and body weight. Tirpatide can improve insulin sensitivity and stimulate insulin release. Improving insulin sensitivity reduces the risk of type 2 diabetes.
Improves cholesterol levels
In the SURPASS-4 clinical trial, tirpatide (15 mg dose):
- Reduced total cholesterol by 6%
- Reduced LDL (bad cholesterol) by 8%
- Reduced triglycerides by 23%
- Boosted HDL (good cholesterol) by 11%
Increases satiety and reduces hunger
Tirzepatide stimulates GLP-1 and GIP receptors, improves insulin sensitivity, increases satiety, and slows the rate at which food moves from the stomach into the intestines. Tirpatide is similar to semaglutide in reducing appetite and energy intake, but is associated with greater fat mass reduction.
Improves cardiovascular health
During the SURPASS clinical trial program and for two years after discontinuation of tirzepatide, tirzepatide significantly reduced the risk of non-fatal stroke, fatal and non-fatal heart attack, and chest pain. There are more clinical trials underway.
Easy to use
As an injectable drug, tirzepatide only needs to be used once a week, which is convenient for users to self-manage at home without frequent medical visits, making treatment more convenient and flexible.
Up to 20% weight reduction
Miracle drug weight loss drug
- Average weight loss of 6.9% after 12 weeks of use
- Average weight loss of 18.4% after 72 weeks of use
- 89.5% of users experience more than 10% loss
- The only currently approved biagonist weight loss drug
How to self-inject tirpatide at home?
Needed supplies including：
- Tirzepatide/B12 drug
- Disposable syringes
- Alcohol Swabs
- Bandages
How Mojoon Works
The Mojoon telemedicine platform is encrypted with HIPAA security levels to ensure the confidentiality and security of your information. The online medical questionnaire has been confirmed by our team of doctors and is designed to obtain the necessary information for diagnosis.
Register and complete questionnaire
Complete your personal information and the questionnaire
Choose your treatment plan and make payment
Pick treatment plan suits your need. Cost is transparent and lower than most insurance copay
Licensed Doctor Review and prescription
Licensed doctors will review prescriptions within 24 hours
Free Discreet Delivery or Local Pickup
Free and discreet delivery of medication to your doorstep or pick up at a local pharmacy,
Tirpatide Frequently Asked Questions
Tirzepatide is an injectable prescription weight loss drug. The United States Food and Drug Administration (FDA) approved its brand name Mounjaro in May 2022. The drug is used to help control blood sugar levels in adults with type 2 diabetes and is also able to suppress appetite and food cravings, leading to significant weight loss.
Tirzepatide works by mimicking the effects of GLP-1 and GIP hormones. It stimulates the release of insulin from the pancreas, reduces glucagon secretion, slows gastric emptying, and promotes satiety. These effects help lower blood sugar levels and promote weight loss.
Tirzepatide has shown significant benefits in controlling blood sugar levels, reducing body weight, and reducing cardiovascular risk, especially in patients with type 2 diabetes.
Tirzepatide is given as a subcutaneous injection (under the skin) once a week. The injections can be self-performed or performed by a medical professional.
Common side effects of tirzepatide include gastrointestinal symptoms such as:
- Nausea
- Vomiting
- Constipation
- Diarrhea
These side effects are usually mild to moderate and improve over time.
Whether it can be combined with other weight loss medications or interventions should be discussed with a medical professional. They can provide guidance on potential interactions, contraindications, and choosing the most appropriate method for your individual situation.
Tirpatide has been shown to improve glycemic control within weeks of initiation of treatment. Maximum weight loss is usually seen after a few months of use.
Tirzepatide can be used alone or in combination with other glucose-lowering drugs such as metformin or insulin, and the specific combination should be determined by a medical professional. For example, if the dose of insulin used in combination with tirzepatide is too high, it can cause dangerous hypoglycemia (hypoglycemia).
Yes, all medications are manufactured at an FDA-registered 503B compound pharmacy that is licensed in all 50 states and uses only the highest quality ingredients. The tirzepatide you purchase is a compounded medicines that are not related to the Lilly™ company or the branded drugs Zepbound® or Mounjaro®.
The retail price of the branded drug Zepbound ranges from around $1,500 per month, depending on the prescribed dose. The treatments offered by Mojoon start at $390 per month and cost $490 per month for the maximum dose
No. Tirzepatide is not recommended for people with a personal or family history of medullary thyroid cancer or multiple endocrine neoplasia type 2 (MEN2).
If you are pregnant, planning to become pregnant, or have a history of pancreatitis, do not use tirpatide.
The $390 monthly fee includes doses of 2.5mg to 10mg per week. Doses of 12.5mg to 15mg per week will incur an additional $100 per month.
As a busy mom, I've been worrying about my weight. The doctor recommended tirpatide to me and I decided to give it a try. After using it for more than two months, I have lost about 10 pounds! What's more, my blood sugar levels are also more stable and I feel a lot more relaxed. Although a little nauseous at first, the side effects quickly disappeared. Now I feel more confident to manage my health and I really think it's a good choice.
Sherry in Los Angeles Tirzepatide